xlnt rogue,seems to like it in the 3's better than 2's ... :-Dlooks like the big buyer/s don't want to push it up too quick, pulled bid by the looks. Waiting for another opportunity. cheers
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%